Categories AlphaGraphs, Earnings, Health Care
Earnings: Agilent’s (A) Q1 2024 profit declines on lower revenues
Healthcare company Agilent Technologies Inc. (NYSE: A) reported a decrease in adjusted earnings for the first quarter of 2024 when its revenues dropped 6% year-over-year.
Net income, on a reported basis, came in at $348 million or $1.18 per share in Q1, compared to $352 million or $1.19 per share in the same period of fiscal 2023. Adjusted earnings decreased 6% year-over-year to $1.29 per share during the three months.
The bottom line was negatively impacted by a 6% decline in revenues to $1.66 billion. For the second quarter, the management expects revenues to be in the range of $1.560 billion to $1.590 billion, and adjusted earnings between $1.17 per share and $1.20 per share.
Agilent’s CEO Mike McMullen said, “We are well positioned for long-term growth driven by our diversified business and multiple growth drivers. While near term market challenges remain, I continue to be optimistic about our future.”
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%